Literature DB >> 19956343

Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics.

Hanna K Sanoff1, Howard L McLeod.   

Abstract

Entities:  

Year:  2008        PMID： 19956343      PMCID： PMC2614280          DOI： 10.1053/j.scrs.2008.09.007

Source DB:  PubMed          Journal:  Semin Colon Rectal Surg        ISSN： 1043-1489


× No keyword cloud information.
  32 in total

1.  Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers.

Authors:  K Kawakami; K Omura; E Kanehira; Y Watanabe
Journal:  Anticancer Res       Date:  1999 Jul-Aug       Impact factor: 2.480

2.  Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients.

Authors:  Hany H Ezzeldin; Adam M Lee; Lori K Mattison; Robert B Diasio
Journal:  Clin Cancer Res       Date:  2005-12-15       Impact factor: 12.531

3.  Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel.

Authors:  M L Rothenberg; N J Meropol; E A Poplin; E Van Cutsem; S Wadler
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

4.  Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group.

Authors:  P C Simmonds
Journal:  BMJ       Date:  2000-09-02

5.  Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU-related toxicity.

Authors:  Nicolas Magné; Marie-Christine Etienne-Grimaldi; Laurent Cals; Nicole Renée; Jean-Louis Formento; Mireille Francoual; Gérard Milano
Journal:  Br J Clin Pharmacol       Date:  2007-03-01       Impact factor: 4.335

6.  Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.

Authors:  C G Leichman; H J Lenz; L Leichman; K Danenberg; J Baranda; S Groshen; W Boswell; R Metzger; M Tan; P V Danenberg
Journal:  J Clin Oncol       Date:  1997-10       Impact factor: 44.544

7.  Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients.

Authors:  Elisabeth Rouits; Michèle Boisdron-Celle; Agnès Dumont; Olivier Guérin; Alain Morel; Erick Gamelin
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

8.  Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival.

Authors:  H J Lenz; C G Leichman; K D Danenberg; P V Danenberg; S Groshen; H Cohen; L Laine; P Crookes; H Silberman; J Baranda; Y Garcia; J Li; L Leichman
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

9.  Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Authors:  Sharlene Gill; Charles L Loprinzi; Daniel J Sargent; Stephan D Thomé; Steven R Alberts; Daniel G Haller; Jacqueline Benedetti; Guido Francini; Lois E Shepherd; Jean Francois Seitz; Roberto Labianca; Wei Chen; Stephen S Cha; Michael P Heldebrant; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2004-04-05       Impact factor: 44.544

10.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

Authors:  Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf O Bechstein; John N Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Laurence Collette; Michel Praet; Ullrich Bethe; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321
View more
  3 in total

1.  Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.

Authors:  Dolly C Penn; YunKyung Chang; Anne-Marie Meyer; Christina DeFilippo Mack; Hanna K Sanoff; Karyn B Stitzenberg; William R Carpenter
Journal:  Cancer       Date:  2014-09-10       Impact factor: 6.860

Review 2.  Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis.

Authors:  Cielito C Reyes-Gibby; Stephanie C Melkonian; Jian Wang; Robert K Yu; Samuel A Shelburne; Charles Lu; Gary Brandon Gunn; Mark S Chambers; Ehab Y Hanna; Sai-Ching J Yeung; Sanjay Shete
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

Review 3.  Precision treatment in colorectal cancer: Now and the future.

Authors:  Tung On Yau
Journal:  JGH Open       Date:  2019-02-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.